97 related articles for article (PubMed ID: 30553464)
21. Molecular pathogenesis of multiple myeloma.
Tonon G
Hematol Oncol Clin North Am; 2007 Dec; 21(6):985-1006, vii. PubMed ID: 17996585
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic studies on human myeloma cell lines.
Jernberg H; Zech L; Nilsson K
Int J Cancer; 1987 Dec; 40(6):811-7. PubMed ID: 3500922
[TBL] [Abstract][Full Text] [Related]
23. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
[TBL] [Abstract][Full Text] [Related]
24. [Cytogenetic study of multiple myeloma].
Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
[TBL] [Abstract][Full Text] [Related]
25. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
Jimenez-Zepeda VH; Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
[TBL] [Abstract][Full Text] [Related]
26. [Molecular genetic methods for the prognostic criteria in multiple myeloma].
Mikala G; Jákó J; Vályi-Nagy I
Orv Hetil; 2005 Aug; 146(32):1673-82. PubMed ID: 16149245
[TBL] [Abstract][Full Text] [Related]
27. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
28. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
29. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Implications of Monosomies in Patients With Multiple Myeloma.
Shin SY; Eom HS; Sohn JY; Lee H; Park B; Joo J; Jang JH; Lee MN; Kim JK; Kong SY
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):159-164.e2. PubMed ID: 28089441
[TBL] [Abstract][Full Text] [Related]
32. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
[TBL] [Abstract][Full Text] [Related]
33. Cellular and molecular genetic features of myeloma and related disorders.
Durie BG
Hematol Oncol Clin North Am; 1992 Apr; 6(2):463-77. PubMed ID: 1582985
[TBL] [Abstract][Full Text] [Related]
34. Structural rearrangements of trisomies are a risk marker of clinical progression in hyperdiploid multiple myeloma.
Alfaro R; Rosell J; Durán MA; Puget G; Besalduch J; Galán P; Vallés A; Bernués M
Anticancer Res; 2011 May; 31(5):1599-602. PubMed ID: 21617215
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47-50 chromosomes and the number of structural abnormalities.
Lim JH; Seo EJ; Park CJ; Jang S; Chi HS; Suh C; Kim H; Kim SR
Eur J Haematol; 2014 Apr; 92(4):313-20. PubMed ID: 24372944
[TBL] [Abstract][Full Text] [Related]
37. Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalities.
Jimenez-Zepeda VH; Chng WJ; Schop RF; Braggio E; Leis JF; Kay N; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):467-76. PubMed ID: 23876845
[TBL] [Abstract][Full Text] [Related]
38. [Chromosome findings in multiple myeloma].
Suzuki K
Nihon Rinsho; 1995 Mar; 53(3):568-73. PubMed ID: 7699887
[TBL] [Abstract][Full Text] [Related]
39. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic abnormalities in 13 patients with multiple myeloma.
Solé F; Woessner S; Acín P; Pérez-Losada A; Florensa L; Besses C; Sans-Sabrafen J
Cancer Genet Cytogenet; 1996 Feb; 86(2):162-4. PubMed ID: 8603346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
